Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.

Collins, P W

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients. [electronic resource] - Haemophilia : the official journal of the World Federation of Hemophilia Jan 2018 - 104-112 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1365-2516

10.1111/hae.13324 doi


Adolescent
Adult
Area Under Curve
Blood Coagulation Factor Inhibitors--blood
Dose-Response Relationship, Drug
Double-Blind Method
Factor IX--adverse effects
Half-Life
Headache--etiology
Hemophilia B--drug therapy
Hemorrhage--prevention & control
Humans
Male
ROC Curve
Recombinant Proteins--pharmacokinetics
Severity of Illness Index
Treatment Outcome
Young Adult